Document is current

Article History

Received: 23 August 2021

Accepted: 6 December 2021

First Online: 10 January 2022

Declarations

:

: Gaurav Syal has served as a consultant for Gilead and Prometheus Laboratories; speaker for HCPLive; and received research support from Pfizer. Miles P Sparrow has received educational grants or research support from Ferring, Orphan, and Gilead; speaker’s fees from Janssen, Abbvie, Ferring, Takeda, Pfizer and Shire; and has served on advisory boards for Janssen, Takeda, Pfizer, Celgene, Abbvie, MSD, Emerge Health, and Gilead. Fernando Velayos has no relevant disclosures. Adam S Cheifetz has served as a consultant for Janssen, Abbvie, Takeda, Pfizer, Samsung, Arena, Bristol Myers Squibb, Prometheus, Bacainn, and Grifols and received research support from Inform Diagnostics. Shane Devlin has served as a speaker or consultant for Abbvie, Janssen, Takeda, Fresenius-Kabi, and Pfizer. Peter M Irving has served as a speaker or a consultant for AbbVie, Arena, Celgene, Ferring, Prometheus, Shire, Warner Chilcott, Takeda, MSD, Vifor Pharma, Pharmacosmos, Topivert, Gilead, Galapagos, BMS, Genentech, Hospira, Samsung Bioepis, VH2, Janssen, Sandoz, and Lilly, Roche; and has received research support from MSD, Pfizer, and Takeda<b>.</b> Gilaad G Kaplan served as a speaker or a consultant for Abbvie, Janssen, Pfizer, Amgen, Gilead, and Takeda; received research support from Ferring, Janssen, Abbvie, Glaxo-Smith Kline, Merck, and Shire; and shares ownership of a patent: TREATMENT OF INFLAMMATORY DISORDERS, AUTOIMMUNE DISEASE, AND PBC. UTI Limited Partnership, assignee. Patent WO2019046959A1. PCT/CA2018/051098. 7 Sept. 2018. Laura Raffals has no relevant disclosures. Thomas Ullman has no relevant disclosures. Krisztina B Gecse has received grants from Pfizer Inc. and Celltrion; consultancy fees from AbbVie, Arena Pharmaceuticals, Galapagos, Gilead, Immunic Therapeutics, Janssen Pharmaceuticals, Novartis, Pfizer Inc., Samsung Bioepis, and Takeda and speaker’s honoraria from Celltrion, Ferring, Janssen Pharmaceuticals, Novartis, Pfizer Inc, Samsung Bioepis, Takeda and Tillotts. Phillip R Fleshner has served as a consultant to Takeda. Amy L Lightner has served as a consultant to Takeda. Corey A Siegel has served as a consultant to Abbvie, BMS, Lilly, Janssen, Pfizer, Prometheus, Takeda, and Trellus Health; speaker for CME activities for Abbvie, Janssen, Pfizer, and Takeda; and received grant support from Abbvie, Janssen, Pfizer, and Takeda. Gil Y Melmed has served as a consultant to Abbvie, Arena, Boehringer-Ingelheim, Bristol-Meyer Squibb/Celgene, Entasis, Janssen, Medtronic, Pfizer, Samsung Bioepis, Shionogi, Takeda, and TechLab and received research funding from Pfizer.